Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis. |
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
Cr2w2Mq4EgpvQQQj
Listen
